Edition:
United Kingdom

UCB Announces Briviact® (Brivaracetam) Now Approved By FDA To Treat Partial-Onset (Focal) Seizures In Pediatric Epilepsy Patients


Monday, 14 May 2018 

Ucb SA ::UCB ANNOUNCES BRIVIACT® (BRIVARACETAM) NOW APPROVED BY FDA TO TREAT PARTIAL-ONSET (FOCAL) SEIZURES IN PEDIATRIC EPILEPSY PATIENTS.